Class I PI 3-kinases: Function and evolution

Advances in Biological Regulation

Volumn 59, Issue , 2015, Pages 53-64

  Kriplani, Nisha ^a   Hermida, Miguel A ^a   Brown, Euan R ^a   Leslie, Nicholas R ^a  

^a HERIOT WATT UNIVERSITY   (United Kingdom)

Author keywords

AKT; Cancer; Evolution; Kinase; Phosphatase; Phosphoinositide; Phylogeny; PI3K; PTEN; Signal Transduction

Indexed keywords

PHOSPHATIDYLINOSITOL; PHOSPHATIDYLINOSITOL 3 KINASE; POLYPHOSPHOINOSITIDE;

ANIMAL; GENETICS; HUMAN; METABOLISM; MOLECULAR EVOLUTION; SIGNAL TRANSDUCTION;

ANIMALS; EVOLUTION, MOLECULAR; HUMANS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHATIDYLINOSITOL PHOSPHATES; PHOSPHATIDYLINOSITOLS; SIGNAL TRANSDUCTION;

EID: 84942553111     PISSN: 22124926     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.jbior.2015.05.002     Document Type: Review

References (100)

1. Alessi D.R., James S.R., Downes C.P., Holmes A.B., Gaffney P.R., Reese C.B., et al. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr Biol 1997, 7:261-269.
2. Astle M.V., Horan K.A., Ooms L.M., Mitchell C.A. The inositol polyphosphate 5-phosphatases: traffic controllers, waistline watchers and tumour suppressors?. Biochem Soc Symp 2007, 161-181.
3. Batty I.H., van der Kaay J., Gray A., Telfer J.F., Dixon M.J., Downes C.P. The control of phosphatidylinositol 3,4-bisphosphate concentrations by activation of the Src homology 2 domain containing inositol polyphosphate 5-phosphatase 2, SHIP2. Biochem J 2007, 407:255-266.
4. Beck J.T., Ismail A., Tolomeo C. Targeting the phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway: an emerging treatment strategy for squamous cell lung carcinoma. Cancer Treat Rev 2014, 40:980-989.
5. Bertin A., McMurray M.A., Thai L., Garcia G., Votin V., Grob P., et al. Phosphatidylinositol-4,5-bisphosphate promotes budding yeast septin filament assembly and organization. J Mol Biol 2010, 404:711-731.
6. Bertrand F.E., McCubrey J.A., Angus C.W., Nutter J.M., Sigounas G. NOTCH and PTEN in prostate cancer. Adv Biol Regul 2014, 56:51-65.
7. Bonneau D., Longy M. Mutations of the human PTEN gene. Hum Mutat 2000, 16:109-122.
8. Brown J.R., Auger K.R. Phylogenomics of phosphoinositide lipid kinases: perspectives on the evolution of second messenger signaling and drug discovery. BMC Evol Biol 2011, 11(4).
9. Burke J.E., Williams R.L. Dynamic steps in receptor tyrosine kinase mediated activation of class IA phosphoinositide 3-kinases (PI3K) captured by H/D exchange (HDX-MS). Adv Biol Regul 2013, 53:97-110.
10. Cantley L.C., Neel B.G. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci U S A 1999, 96:4240-4245.
11. Chardin P., Paris S., Antonny B., Robineau S., Beraud-Dufour S., Jackson C.L., et al. A human exchange factor for ARF contains Sec7- and pleckstrin-homology domains. Nature 1996, 384:481-484.
12. Charest P.G., Firtel R.A. Feedback signaling controls leading-edge formation during chemotaxis. Curr Opin Genet Dev 2006, 16:339-347.
13. Charest P.G., Firtel R.A. Big roles for small GTPases in the control of directed cell movement. Biochem J 2007, 401:377-390.
14. Clark J., Kay R.R., Kielkowska A., Niewczas I., Fets L., Oxley D., et al. Dictyostelium uses ether-linked inositol phospholipids for intracellular signalling. EMBO J 2014, 33:2188-2200.
15. Cox S.S., van der Giezen M., Tarr S.J., Crompton M.R., Tovar J. Evidence from bioinformatics, expression and inhibition studies of phosphoinositide-3 kinase signalling in Giardia intestinalis. BMC Microbiol 2006, 6:45.
16. Dixon M.J., Gray A., Boisvert F.M., Agacan M., Morrice N.A., Gourlay R., et al. A screen for novel phosphoinositide 3-kinase effector proteins. Mol Cell Proteomics 2011, 10. M110 003178.
17. Dixon M.J., Gray A., Schenning M., Agacan M., Tempel W., Tong Y., et al. IQGAP proteins reveal an atypical phosphoinositide (aPI) binding domain with a pseudo C2 domain fold. J Biol Chem 2012, 287:22483-22496.
18. Dowler S., Currie R.A., Campbell D.G., Deak M., Kular G., Downes C.P., et al. Identification of pleckstrin-homology-domain-containing proteins with novel phosphoinositide-binding specificities. Biochem J 2000, 351:19-31.
19. Downes C.P., Bennett D., McConnachie G., Leslie N.R., Pass I., MacPhee C., et al. Antagonism of PI 3-kinase-dependent signalling pathways by the tumour suppressor protein, PTEN. Biochem Soc Trans 2001, 29:846-851.
20. Downes C.P., Carter A.N. Phosphoinositide 3-kinase: a new effector in signal transduction?. Cell Signal 1991, 3:501-513.
21. Dyson J.M., Fedele C.G., Davies E.M., Becanovic J., Mitchell C.A. Phosphoinositide phosphatases: just as important as the kinases. Sub-cellular Biochem 2012, 58:215-279.
22. Engelman J.A., Luo J., Cantley L.C. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 2006, 7:606-619.
23. Fayard E., Tintignac L.A., Baudry A., Hemmings B.A. Protein kinase B/Akt at a glance. J Cell Sci 2005, 118:5675-5678.
24. Fritsch R., de Krijger I., Fritsch K., George R., Reason B., Kumar M.S., et al. RAS and RHO families of GTPases directly regulate distinct phosphoinositide 3-kinase isoforms. Cell 2013, 153:1050-1063.
25. Fruman D.A., Meyers R.E., Cantley L.C. Phosphoinositide kinases. Annu Rev Biochem 1998, 67:481-507.
26. Gewinner C., Wang Z.C., Richardson A., Teruya-Feldstein J., Etemadmoghadam D., Bowtell D., et al. Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling. Cancer Cell 2009, 16:115-125.
27. Haslam R.J., Koide H.B., Hemmings B.A. Pleckstrin domain homology. Nature 1993, 363:309-310.
28. Hirsch E., Katanaev V.L., Garlanda C., Azzolino O., Pirola L., Silengo L., et al. Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science 2000, 287:1049-1053. (New York, NY.
29. Hopkins B.D., Fine B., Steinbach N., Dendy M., Rapp Z., Shaw J., et al. A secreted PTEN phosphatase that enters cells to alter signaling and survival. Science 2013, 341:399-402. (New York, NY.
30. Iijima M., Huang Y.E., Devreotes P. Temporal and spatial regulation of chemotaxis. Dev Cell 2002, 3:469-478.
31. Jia S., Liu Z., Zhang S., Liu P., Zhang L., Lee S.H., et al. Essential roles of PI(3)K-p110beta in cell growth, metabolism and tumorigenesis. Nature 2008, 454:776-779.
32. Jungmichel S., Sylvestersen K.B., Choudhary C., Nguyen S., Mann M., Nielsen M.L. Specificity and commonality of the phosphoinositide-binding proteome analyzed by quantitative mass spectrometry. Cell Rep 2014, 6:578-591.
33. Katso R., Okkenhaug K., Ahmadi K., White S., Timms J., Waterfield M.D. Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer. Annu Rev Cell Dev Biol 2001, 17:615-675.
34. Kawashima T., Tokuoka M., Awazu S., Satoh N., Satou Y. A genomewide survey of developmentally relevant genes in Ciona intestinalis. VIII. Genes for PI3K signaling and cell cycle. Dev Genes Evol 2003, 213:284-290.
35. Klarlund J.K., Guilherme A., Holik J.J., Virbasius J.V., Chawla A., Czech M.P. Signaling by phosphoinositide-3,4,5-trisphosphate through proteins containing pleckstrin and Sec7 homology domains. Science 1997, 275:1927-1930.
36. Krugmann S., Anderson K.E., Ridley S.H., Risso N., McGregor A., Coadwell J., et al. Identification of ARAP3, a novel PI3K effector regulating both Arf and Rho GTPases, by selective capture on phosphoinositide affinity matrices. Mol Cell 2002, 9:95-108.
37. Kurokawa T., Takasuga S., Sakata S., Yamaguchi S., Horie S., Homma K.J., et al. 3' Phosphatase activity toward phosphatidylinositol 3,4-bisphosphate [PI(3,4)P2] by voltage-sensing phosphatase (VSP). Proc Natl Acad Sci U S A 2012, 109:10089-10094.
38. Lee J.S., Kim J.H., Jang I.H., Kim H.S., Han J.M., Kazlauskas A., et al. Phosphatidylinositol (3,4,5)-trisphosphate specifically interacts with the phox homology domain of phospholipase D1 and stimulates its activity. J Cell Sci 2005, 118:4405-4413.
39. Lemmon M.A. Membrane recognition by phospholipid-binding domains. Nat Rev Mol Cell Biol 2008, 9:99-111.
40. Leslie N.R., Batty I.H., Maccario H., Davidson L., Downes C.P. Understanding PTEN regulation: PIP2, polarity and protein stability. Oncogene 2008, 27:5464-5476.
41. Leslie N.R., Dixon M.J., Schenning M., Gray A., Batty I.H. Distinct inactivation of PI3K signalling by PTEN and 5-phosphatases. Adv Biol Regul 2012, 52:205-213.
42. Leslie N.R., Foti M. Non-genomic loss of PTEN function in cancer: not in my genes. Trends Pharmacol Sci 2011, 32:131-140.
43. Li J., Yen C., Liaw D., Podsypanina K., Bose S., Wang S.I., et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997, 275:1943-1947. (New York, NY.
44. Liu H., Radisky D.C., Wang F., Bissell M.J. Polarity and proliferation are controlled by distinct signaling pathways downstream of PI3-kinase in breast epithelial tumor cells. J Cell Biol 2004, 164:603-612.
45. Lucas N., Cho W. Phosphatidylserine binding is essential for plasma membrane recruitment and signaling function of 3-phosphoinositide-dependent kinase-1. J Biol Chem 2011, 286:41265-41272.
46. Maier U., Babich A., Nurnberg B. Roles of non-catalytic subunits in gbetagamma-induced activation of class I phosphoinositide 3-kinase isoforms beta and gamma. J Biol Chem 1999, 274:29311-29317.
47. Manning B.D., Cantley L.C. AKT/PKB signaling: navigating downstream. Cell 2007, 129:1261-1274.
48. Martelli A.M., Lonetti A., Buontempo F., Ricci F., Tazzari P.L., Evangelisti C., et al. Targeting signaling pathways in T-cell acute lymphoblastic leukemia initiating cells. Adv Biol Regul 2014, 56:6-21.
49. Martin-Belmonte F., Yu W., Rodriguez-Fraticelli A.E., Ewald A.J., Werb Z., Alonso M.A., et al. Cell-polarity dynamics controls the mechanism of lumen formation in epithelial morphogenesis. Curr Biol: CB 2008, 18:507-513.
50. Mayer B.J., Ren R., Clark K.L., Baltimore D. A putative modular domain present in diverse signaling proteins. Cell 1993, 73:629-630.
51. McConnachie G., Pass I., Walker S.M., Downes C.P. Interfacial kinetic analysis of the tumour suppressor phosphatase, PTEN: evidence for activation by anionic phospholipids. Biochem J 2003, 371:947-955.
52. Michell R.H. Inositol derivatives: evolution and functions. Nat Rev Mol Cell Biol 2008, 9:151-161.
53. Mitra P., Zhang Y., Rameh L.E., Ivshina M.P., McCollum D., Nunnari J.J., et al. A novel phosphatidylinositol(3,4,5)P3 pathway in fission yeast. J Cell Biol 2004, 166:205-211.
54. Mora A., Komander D., van Aalten D.M., Alessi D.R. PDK1, the master regulator of AGC kinase signal transduction. Semin Cell Dev Biol 2004, 15:161-170.
55. Myers M.P., Pass I., Batty I.H., Van der Kaay J., Stolarov J.P., Hemmings B.A., et al. The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc Natl Acad Sci U S A 1998, 95:13513-13518.
56. Nagel W., Zeitlmann L., Schilcher P., Geiger C., Kolanus J., Kolanus W. Phosphoinositide 3-OH kinase activates the beta2 integrin adhesion pathway and induces membrane recruitment of cytohesin-1. J Biol Chem 1998, 273:14853-14861.
57. Nozaki H., Maruyama S., Matsuzaki M., Nakada T., Kato S., Misawa K. Phylogenetic positions of Glaucophyta, green plants (Archaeplastida) and Haptophyta (Chromalveolata) as deduced from slowly evolving nuclear genes. Mol Phylogenet Evol 2009, 53:872-880.
58. Okkenhaug K., Bilancio A., Farjot G., Priddle H., Sancho S., Peskett E., et al. Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice. Science 2002, 297:1031-1034. (New York, NY.
59. Ooms L.M., Horan K.A., Rahman P., Seaton G., Gurung R., Kethesparan D.S., et al. The role of the inositol polyphosphate 5-phosphatases in cellular function and human disease. Biochem J 2009, 419:29-49.
60. Paradis S., Ruvkun G. Caenorhabditis elegans Akt/PKB transduces insulin receptor-like signals from AGE-1 PI3 kinase to the DAF-16 transcription factor. Genes Dev 1998, 12:2488-2498.
61. Parfrey L.W., Grant J., Tekle Y.I., Lasek-Nesselquist E., Morrison H.G., Sogin M.L., et al. Broadly sampled multigene analyses yield a well-resolved eukaryotic tree of life. Syst Biol 2010, 59:518-533.
62. Park W.S., Heo W.D., Whalen J.H., O'Rourke N.A., Bryan H.M., Meyer T., et al. Comprehensive identification of PIP3-regulated PH domains from C. elegans to H. sapiens by model prediction and live imaging. Mol Cell 2008, 30:381-392.
63. Parker P.J., Waterfield M.D. Phosphatidylinositol 3-kinase: a novel effector. Cell Growth Differ 1992, 3:747-752.
64. Poliseno L., Salmena L., Zhang J., Carver B., Haveman W.J., Pandolfi P.P. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 2010, 465:1033-1038.
65. Posor Y., Eichhorn-Gruenig M., Puchkov D., Schoneberg J., Ullrich A., Lampe A., et al. Spatiotemporal control of endocytosis by phosphatidylinositol-3,4-bisphosphate. Nature 2013, 499:233-237.
66. Premkumar L., Bobkov A.A., Patel M., Jaroszewski L., Bankston L.A., Stec B., et al. Structural basis of membrane targeting by the Dock180 family of Rho family guanine exchange factors (Rho-GEFs). J Biol Chem 2010, 285:13211-13222.
67. Rodriguez-Escudero I., Roelants F.M., Thorner J., Nombela C., Molina M., Cid V.J. Reconstitution of the mammalian PI3K/PTEN/Akt pathway in yeast. Biochem J 2005, 390:613-623.
68. Rogozin I.B., Basu M.K., Csuros M., Koonin E.V. Analysis of rare genomic changes does not support the unikont-bikont phylogeny and suggests cyanobacterial symbiosis as the point of primary radiation of eukaryotes. Genome Biol Evol 2009, 1:99-113.
69. Rohrschneider L.R., Fuller J.F., Wolf I., Liu Y., Lucas D.M. Structure, function, and biology of SHIP proteins. Genes Dev 2000, 14:505-520.
70. Salmena L., Carracedo A., Pandolfi P.P. Tenets of PTEN tumor suppression. Cell 2008, 133:403-414.
71. Sarbassov D.D., Guertin D.A., Ali S.M., Sabatini D.M. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 2005, 307:1098-1101. (New York, NY.
72. Sasaki T., Irie-Sasaki J., Jones R.G., Oliveira-dos-Santos A.J., Stanford W.L., Bolon B., et al. Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration. Science 2000, 287:1040-1046. (New York, NY.
73. Shi S.H., Jan L.Y., Jan Y.N. Hippocampal neuronal polarity specified by spatially localized mPar3/mPar6 and PI 3-kinase activity. Cell 2003, 112:63-75.
74. Silva A., Yunes J.A., Cardoso B.A., Martins L.R., Jotta P.Y., Abecasis M., et al. PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability. J Clin Invest 2008, 118:3762-3774.
75. Stambolic V., Suzuki A., de la Pompa J.L., Brothers G.M., Mirtsos C., Sasaki T., et al. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 1998, 95:29-39.
76. Steck P.A., Pershouse M.A., Jasser S.A., Yung W.K., Lin H., Ligon A.H., et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997, 15:356-362.
77. Stephens L., Anderson K., Stokoe D., Erdjument-Bromage H., Painter G.F., Holmes A.B., et al. Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. Science 1998, 279:710-714.
78. Stephens L., Hawkins P. Signalling via class IA PI3Ks. Adv Enzyme Regul 2011, 51:27-36.
79. Stocker H., Andjelkovic M., Oldham S., Laffargue M., Wymann M.P., Hemmings B.A., et al. Living with lethal PIP3 levels: viability of flies lacking PTEN restored by a PH domain mutation in Akt/PKB. Science 2002, 295:2088-2091. (New York, NY.
80. Strahl T., Thorner J. Synthesis and function of membrane phosphoinositides in budding yeast, Saccharomyces cerevisiae. Biochimica Biophys Acta 2007, 1771:353-404.
81. Tang X., Downes C.P. Purification and characterization of Gbetagamma-responsive phosphoinositide 3-kinases from pig platelet cytosol. J Biol Chem 1997, 272:14193-14199.
82. Toker A., Marmiroli S. Signaling specificity in the Akt pathway in biology and disease. Adv Biol Regul 2014, 55:28-38.
83. Vanhaesebroeck B., Guillermet-Guibert J., Graupera M., Bilanges B. The emerging mechanisms of isoform-specific PI3K signalling. Nat Rev Mol Cell Biol 2010, 11:329-341.
84. Vanhaesebroeck B., Leevers S.J., Ahmadi K., Timms J., Katso R., Driscoll P.C., et al. Synthesis and function of 3-Phosphorylated inositol lipids. Annu Rev Biochem 2001, 70:535-602.
85. Vanhaesebroeck B., Leevers S.J., Panayotou G., Waterfield M.D. Phosphoinositide 3-kinases: a conserved family of signal transducers. Trends Biochem Sci 1997, 22:267-272.
86. Vanhaesebroeck B., Stephens L., Hawkins P. PI3K signalling: the path to discovery and understanding. Nat Rev Mol Cell Biol 2012, 13:195-203.
87. Vanhaesebroeck B., Vogt P.K., Rommel C. PI3K: from the bench to the clinic and back. Curr Top Microbiol Immunol 2010, 347:1-19.
88. Vanhaesebroeck B., Welham M.J., Kotani K., Stein R., Warne P.H., Zvelebil M.J., et al. P110delta, a novel phosphoinositide 3-kinase in leukocytes. Proc Natl Acad Sci U S A 1997, 94:4330-4335.
89. Venkateswarlu K., Oatey P.B., Tavare J.M., Cullen P.J. Insulin-dependent translocation of ARNO to the plasma membrane of adipocytes requires phosphatidylinositol 3-kinase. Curr Biol : CB 1998, 8:463-466.
90. Vivanco I., Sawyers C.L. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2002, 2:489-501.
91. Walker S.M., Downes C.P., Leslie N.R. TPIP: a novel phosphoinositide 3-phosphatase. Biochem J 2001, 360:277-283.
92. Watton S.J., Downward J. Akt/PKB localisation and 3' phosphoinositide generation at sites of epithelial cell-matrix and cell-cell interaction. Curr Biol 1999, 9:433-436.
93. Weiner O.D. Regulation of cell polarity during eukaryotic chemotaxis: the chemotactic compass. Curr Opin Cell Biol 2002, 14:196-202.
94. Whitman M., Downes C.P., Keeler M., Keller T., Cantley L. Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate. Nature 1988, 332:644-646.
95. Worby C.A., Dixon J.E. Pten. Annu Rev Biochem 2014, 83:641-669.
96. Wymann M.P., Pirola L. Structure and function of phosphoinositide 3-kinases. Biochim Biophys Acta 1998, 1436:127-150.
97. Yang J., Cron P., Good V.M., Thompson V., Hemmings B.A., Barford D. Crystal structure of an activated Akt/protein kinase B ternary complex with GSK3-peptide and AMP-PNP. Nat Struct Biol 2002, 9:940-944.
98. Yu J., Zhang Y., McIlroy J., Rordorf-Nikolic T., Orr G.A., Backer J.M. Regulation of the p85/p110 phosphatidylinositol 3'-kinase: stabilization and inhibition of the p110alpha catalytic subunit by the p85 regulatory subunit. Mol Cell Biol 1998, 18:1379-1387.
99. Yu J.W., Mendrola J.M., Audhya A., Singh S., Keleti D., DeWald D.B., et al. Genome-wide analysis of membrane targeting by S. cerevisiae pleckstrin homology domains. Mol Cell 2004, 13:677-688.
100. Yuan T.L., Cantley L.C. PI3K pathway alterations in cancer: variations on a theme. Oncogene 2008, 27:5497-5510.